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Coxiella burnetii, the etiological agent of acute and chronic Q fever in humans, is a naturally intracellular pathogen that directs
the formation of an acidic Coxiella-containing vacuole (CCV) derived from the host lysosomal network. Central to its pathogen-
esis is a specialized type IVB secretion system (T4SS) that delivers effectors essential for intracellular replication and CCV for-
mation. Using a bioinformatics-guided approach, 234 T4SS candidate substrates were identified. Expression of each candidate as
a TEM-1-lactamase fusion protein led to the identification of 53 substrates that were translocated in a Dot/Icm-dependent
manner. Ectopic expression in HeLa cells revealed that these substrates trafficked to distinct subcellular sites, including the en-
doplasmic reticulum, mitochondrion, and nucleus. Expression in Saccharomyces cerevisiae identified several substrates that
were capable of interfering with yeast growth, suggesting that these substrates target crucial host processes. To determine if any
of these T4SS substrates are necessary for intracellular replication, we isolated 20 clonal T4SS substrate mutants using theHi-
mar1 transposon and transposase. Among these, 10 mutants exhibited defects in intracellular growth and CCV formation in
HeLa and J774A.1 cells but displayed normal growth in bacteriological medium. Collectively, these results indicate that C. bur-
netii encodes a large repertoire of T4SS substrates that play integral roles in host cell subversion and CCV formation and suggest
less redundancy in effector function than has been found in the comparative LegionellaDot/Icmmodel.
Coxiella burnetii, a Gram-negative naturally obligate intracellu-lar pathogen, is the etiological agent of Q fever, a zoonotic
disease predominately associated with domestic livestock. This
highly infectious organism is usually acquired via inhalation of
contaminated aerosols, where it manifests as an acute, influenza-
like illness that is typically self-limiting and readily resolves with-
out antibiotic treatment. However, in rare but serious instances,
chronicQ fever can develop and generally presents as endocarditis
or hepatitis (1).
Actin-dependent endocytosis of C. burnetii by macrophages
leads to internalization in an early endosome and trafficking
through the default endocytic pathway to ultimately establish an
acidic Coxiella-containing vacuole (CCV) derived from the host
lysosomal network (2). While the nascent CCV readily acquires
Rab5 andRab7,markers of early and late endosomes, respectively,
fusion with the lysosome is delayed compared to that seen with
phagosomes harboring latex beads (3). During this initial stall, the
Coxiella-containing phagosome undergoes repeated fusions with
autophagosomes, an interaction that is believed to deliver nutri-
ents to the organism (4). Following this delay, the phagosome
fuses with the lysosome and the bacteria transition from a non-
replicative small-cell variant (SCV) to the replicative large-cell
variant (LCV) (5). As replication ensues, the Coxiella-containing
vacuole expands to ultimately occupy most of the host cell cyto-
plasm and undergoes repeated fusions with autophagosomes, en-
dolysosomes, and, at later time points, vesicles from the early se-
cretory pathway (4, 6). Establishment of this intracellular niche is
dependent on active bacterial protein synthesis (7) and requires
manipulation of numerous host cell processes. These include in-
duction of autophagy (4), inhibition of apoptosis (8), modifica-
tion of kinases and phosphatases (9, 10), modulation of the host
transcriptome (11), and recruitment of secretory components (6).
Intracellular replication and CCV formation are dependent on
a type IVB secretion system (T4SS) that is homologous to the
Dot/Icm system of Legionella pneumophila (12, 13). In Legionella,
this system is encoded by 26 dot/icm (defect in organelle traffick-
ing/intracellular multiplication) genes (14, 15), 18 of which are
homologous to components of the tra/trb-encoded DNA conju-
gative machinery (1). Together, these components form a pilus-
like structure that presumably spans the inner and outer bacterial
membranes and forms a translocation pore through the Legion-
ella-containing vacuole (LCV), allowing delivery of bacterial ef-
fector proteins into the host cell cytosol (10). The Dot/Icm system
of Coxiella consists of 23 of these Dot/Icm components, lacking
homologs of IcmR, DotJ, and DotV (16).
These systems are functionally analogous, as demonstrated by
cross-complementation of Legionellamutants with Coxiella dotB,
icmS, icmW, and icmT (17). This similarity has allowed research-
ers to succeed in using the genetically tractable L. pneumophila as
a surrogate host to identify C. burnetii T4SS substrates (8, 18–20).
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However, only a few of the effectors are conserved, which is con-
sistent with the different properties of the vacuoles occupied by
these two pathogens. Whereas C. burnetii thrives in an acidic,
autophagosome-like vacuole, L. pneumophila resides in a vacuole
with a neutral pH derived from the host endoplasmic reticulum
(ER) (1). Additionally, substantial differences in host range exist,
with Legionella predominately associated with protists and Cox-
iella associated with a variety of mammalian species. To date, ap-
proximately 50 T4SS substrates have been identified in C. burnetii
using bacterial two-hybrid assays (18), genomic assays (8), and
open reading frames (ORFs) with predicted eukaryote-like do-
mains (18–21) as possessing the ability to serve as Dot/Icm-de-
pendent secretion substrates.
The goal of the current study was to more comprehensively
identify C. burnetii T4SS substrates using an enhanced bioinfor-
matics-guided approach. TheC. burnetii genomewas screened for
ORFs that contained a PmrA regulatory consensus sequence
within the predicted promoter region (18, 22) or an E-blockmotif
(23) or were homologs of known effectors. Using this approach,
we identified 53 T4SS substrates, 46 of which have not been pre-
viously reported. Ectopic expression in mammalian cells and het-
erologous expression in Saccharomyces cervisiae revealed that
these substrates traffic to distinct subcellular compartments and
modulate crucial host processes. The use of theHimar1-mediated
random mutagenesis method resulted in the generation of 20
clonal T4SS substrate mutants, 10 of which were defective in in-
tracellular replication and CCV formation. Overall, the results of
this study suggest that C. burnetii encodes a large repertoire of
secretion substrates that play integral roles in host cell subversion,
intracellular replication, and CCV formation and suggest less
functional redundancy than is seen with the comparative Legion-
ellamodel.
MATERIALS AND METHODS
Bacteria and host cell lines.Bacteria used for this study are listed in Table
S1 in the supplemental material. C. burnetii Nine Mile phase II (NMII),
clone 4 (RSA439), was propagated in modified acidified citrate cysteine
medium (ACCM-2) under microaerophilic conditions as previously de-
scribed (24). When required, 350 g/ml kanamycin or 5 g/ml chloram-
phenicol was added. L. pneumophila strains Lp02 and Lp03 (a mutant
lacking dotA) were maintained on charcoal yeast extract (CYE) agar or
N-(2-acetamido)-2-aminoethanesulfonic acid (ACES) broth–yeast ex-
tract (AYE) broth, and 5 g/ml chloramphenicol was added as needed.
HeLa, Hek293T, and J774A.1 cells were cultured in Dulbecco’s mod-
ified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS).
THP-1 and U937 cells were propagated in RPMI medium with 10% FBS.
All cell lines were maintained at 37°C with 5% CO2.
Bioinformatics analysis. For bioinformatics prediction of C. burnetii
T4SS candidate substrates, RSA493 and L. pneumophila Philadelphia 1
genomes were acquired from the J. Craig Venter Institute Comprehensive
Microbial Resource (http://cmr.jcvi.org/cgi-bin/CMR/GenomePage.cgi
?orggcb). T4SS candidate substrates were selected based on the presence
of one of the following three features: a PmrA consensus regulatory se-
quence in the promoter region, an E-block motif, or a homolog to a
Legionella effector.
We recently reported the identification of 126 putative PmrA-regu-
lated C. burnetii ORFs; however, only 35 of these candidate substrates
were tested for Dot/Icm-dependent translocation (18).We included 83 of
the untested putative PmrA-regulated genes in the current study.
We scanned the last 30 amino acids corresponding to all C. burnetii
RSA493 genes encoding proteins for enrichment in glutamate, termed the
E-block motif (23). Using this algorithm, we identified 328 ORFs that
encoded similarmotifs. Among these, 122ORFs encode hypothetical pro-
teins that were retained in the candidate pool.
Lastly, we scanned the C. burnetii genome for similarity to the newly
identified 70 Legionella effector proteins (25). To accomplish this, we used
all-against-all searches of C. burnetii RSA493 proteins using local
BLAST-P. This approach resulted in the identification of 42 candidates, 29
of which were excluded based on their predicted function or conservation
among Gram-negative bacteria.
Plasmid construction. To examine Dot/Icm-dependent protein
translocation in C. burnetii, we generated the kanamycin-resistant TEM
vector, pCC108, by removing the chloramphenicol resistance marker
(Cmr) andmCherry from pKM244 (KatjaMertens, James P. Berg, Robert
E. Brennan, Mary M. Weber, Chen Chen, and James E. Samuel, unpub-
lished data) using HindIII digestion and replaced it with a PCR-amplified
pHSP10-EGFP-pCbu1910-Kanr selection marker cassette. A pCbu1910-
Flag tags-TEM1-BamHI cassette was assembled using splicing by overlap
extension (SOEing) PCR, and the resulting cassette was cloned into the
SacI/SalI sites to generate pCC108. Identified T4SS substrates were cloned
into the BamHI/SalI sites of pCC108 or pCBTEM to generate N-terminal
TEM1 fusion proteins.
For ectopic expression and yeast toxicity experiments, all identified
T4SS substrates were PCR amplified and cloned into BglII/SalI sites of
pEGFPC1 (BD Clontech, Mountain View, CA) to generate C-terminal
enhanced greenfluorescent protein (EGFP) fusions or BamHI/SalI sites of
pYesNTA2 (Invitrogen, Carlsbad, CA). For substrates possessing BamHI
or SalI sites in the target gene, BglII or XhoI was used.
TEM translocation assays. TEM translocation assays for L. pneumo-
phila and C. burnetii in U937 and THP-1 cells, respectively, were con-
ducted as previously described (18). L. pneumophilawas transformedwith
pCBTEM and C. burnetii with pCC108 or pCBTEM. Individual L. pneu-
mophila and C. burnetii colonies expressing the -lactamase fusion pro-
tein were selected and propagated in AYE and ACCM-2 broth, respec-
tively. Where needed, expression of fusion proteins was induced with 1
mM isopropyl--D-1-thiogalactopyranoside (IPTG) for 48 h. Host cells
were seeded at 105/ml in 24-well plates andwere inoculated at amultiplic-
ity of infection (MOI) of 30 and incubated for 3 h for infection with L.
pneumophila or at an MOI of 100 and incubated for 48 h for C. burnetii.
The L. pneumophila- or C. burnetii-infected cells were loaded with 50 l
6XCCF4/AM solution (LiveBLAzer-FRET B/G loading kit; Invitrogen)
and incubated at room temperature for 2 h or 4 h, respectively. The per-
centage of blue cells was quantified using a Nikon A1 imaging system
equipped with a Chroma -lactamase filter set (Chroma no. 41031) (ex-
citation, 405 nm; emission, 435 nm [long pass]). For substrates exhibiting
translocation rates above 10%, approximately 1,000 cells were counted;
however, for substrates exhibiting low (less than 10%) translocation rates,
approximately 5,000 cells were counted. Results are presented as mean
values determined from triplicate wells from at least two independent
experiments.
Ectopic expression in HeLa cells. To determine subcellular localiza-
tion of C. burnetii T4SS substrates, HeLa cells were seeded in 24-well
glass-bottom dishes at a density of 105/ml. Where indicated, cells were
infected at an MOI of 100 with mCherry expressing C. burnetii-pKM244.
At 72 h postinfection, infected or uninfected cells were transiently trans-
fected with EGFP fusion constructs using Lipofectamine (Invitrogen) and
following the guidelines outlined by the manufacturer. At 24 h posttrans-
fection, cells were fixed with 4% formaldehyde and permeabilized with
ice-cold methanol and nuclei were stained with 1 Hoechst stain. For
colocalization analysis, primary antibodies were diluted in 1% bovine
serum albumin (BSA) and used at the following concentrations: anti-CoxIV
(GenScript, Piscataway, NJ) at 1:250 and anti-calnexin (GenScript) at 1:250.
Primary antibodies were detected using Alexa Fluor 555 (Cell Signaling,
Boston, MA) at 1:1,000 diluted in 1% BSA. To assess colocalization with
autophagosomes, cells were cotransformed with EGFP-tagged substrates
and pmRFP-LC3 (Addgene, Cambridge, MA). Fluorescence images were
acquired with a Nikon-A1 microscope using the 60 oil immersion ob-
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jective, and images were processed using NIS-Elements software. Similar
results were obtained from at least three independent experiments per-
formed with at least 100 transfected cells per experiment.
Yeast toxicity assay. To assess the toxicity of C. burnetii T4SS sub-
strates in yeast, each ORF was cloned into pYesNTA2 as BamHI/SalI PCR
fragments, and the resulting constructs were transformed into Saccharo-
myces cerevisiae strain W303 using a standard transformation protocol
(26). Transformants were plated on uracil dropout media, supplemented
with glucose, and incubated for 72 h at 30°C. Five colonies from each
transformation were expanded, and toxicity was assessed by serially dilut-
ing and spotting onto the appropriate dropout media (27). Toxicity re-
sults were determined from at least three independent experiments.
SEAP assay. To identify T4SS substrates that disrupt the secretory
pathway,Hek293T cells were cotransformedwith pSEAP andpEGFP con-
structs expressing the T4SS substrates. Twenty-four hours posttransfec-
tion, cells were washed with 1 phosphate-buffered saline (PBS) and
incubated for an additional 8 h. Following the allotted incubation period,
the culture supernatant was collected to calculate the extracellular se-
creted embryonic alkaline phosphatase (SEAP) levels. For determination
of intracellular SEAP levels, cells were lysed (28) and fractions measured
for alkaline phosphatase activity using a Phospha-Light system (Invitro-
gen) as described by the manufacturer. Results were tabulated from at
least 2 independent experiments with at least 3 replicates per experiment.
GenerationofC. burnetii transposonmutants.C. burnetii, axenically
cultured inACCM-2, waswashed twice and resuspended in distilledwater
to an approximate concentration of 109 cells/ml. Bacterial cells were
mixed with 1 g of pKM225 plasmid DNA, and electroporation was per-
formed as previously described (24). After 7 days, individual colonieswere
picked and expanded in ACCM-2. Genomic DNA was isolated for rescue
cloning using a GenElute bacterial genomic DNA kit (Sigma, St. Louis,
MO). Purified DNA was digested with HindIII (New England BioLabs,
Ipswich, MA), ligated with T4 DNA ligase (New England BioLabs), and
transformed into chemically competent Escherichia coli DH5. To deter-
mine the genomic insertion site of theHimar1 transposon, three colonies
per transformation were sequenced using ColE1-R (5=-CTTTCCTGCAC
TAGATCCCC-3=) and CatF (5=-GTACTGCGATGAGTGGCAG-3=).
Growth curve analysis of T4SS substrate mutants. For growth curve
comparisons of C. burnetii T4SS substrate mutants, the concentration of
C. burnetii strains axenically cultured in ACCM-2 was determined using
quantitative PCR (qPCR) with IS1111 gene-specific primers (29). To first
verify that the mutants had comparable growth rates in axenic culture,
determinations of curves in ACCM-2 were conducted by inoculating 20
ml ACCM-2 with 106 cells/ml of RSA439, RSA439 icmX::Tn, or RSA439
specific T4SS substrate mutants. At 1 day, 4 days, and 7 days postinocula-
tion, 1 ml of culture was removed, pelleted, and resuspended in 200 l of
DNA lysis solution with 10 l of 20 mg/ml proteinase K (30). For cell
culture comparisons, J774A.1 or HeLa cells were seeded in 24-well plates
to a density of 105 cells/ml. Cells were infected at an MOI of 50 with C.
burnetii (RSA439), RSA439 icmX::Tn, or RSA439 specific T4SS substrate
mutants in triplicate. At 4 h postinfection, cells were washed twice with
1 PBS to remove uninternalized bacteria, fresh medium was added to
each well, and cultures were incubated at 37°C with 5% CO2. At 1 day, 4
days, and 7 days, cells were harvested using trypsinization (HeLa) or
scraped (J774A.1) and resuspended in 200 l of DNA lysis solution with
10 l of 20 mg/ml proteinase K (30). DNA was isolated from the infected
cells and ACCM-2 cultures using a High Pure PCR Template Prep kit
(Roche Applied Sciences, Indianapolis, IN), and purified DNAwas quan-
tified using qPCR with TaqMan and primers specific for IS1111 (29). At
least three independent growth curves for axenic and cell culture were
determined with at least three samples per experiment.
Coinfection. For coinfection experiments, HeLa cells were seeded at a
density of 105 cells/ml onto glass-bottom 24-well plates. Cells were in-
fected at an MOI of 100 with either wild-type RSA439 or specific T4SS
substratemutants or coinfected with wild-type andmutant strains at a 1:1
ratio. At 4 h postinfection, noninternalized bacteria were removed by two
washes with 1 PBS and fresh culture medium was added. Cultures were
propagated for an additional 7 days. Following infection, cells were
washed, fixed with 4% formaldehyde, and DNA was stained with 1
Hoechst stain. Fluorescence images were acquired with a Nikon-A1 mi-
croscope using the 60 oil immersion objective, and images were pro-
cessed using NIS-Elements software. Similar results were obtained from
three independent experiments performed with at least 50 infected cells
per experiment.
RESULTS
Identification of novel C. burnetii T4SS substrates by bioinfor-
matics screening. In silico analyses have succeeded in the predic-
tion of putative secretion substrates in bacterial pathogens (18, 23,
31). The use of these computational tools allows one to reduce the
number of candidates to an experimentally manageable level. In
the current study, we expanded the number of C. burnetii type IV
substrates using three parameters: a consensus promoter element
in PmrA regulation (18, 22), an E-blockmotif (23), and homology
to known effectors (25).
The two-component regulatory system PmrA-PmrB regulates
several dot/icm genes and genes encoding T4SS substrates (22). A
recent study revealed that 35 L. pneumophila and 68 C. burnetii
ORFs contain the PmrA regulatory elements TTAA-N6-TTAA
(22). In L. pneumophila, some of these ORFs code for bona fide
Dot/Icm substrates, suggesting the usefulness of this prediction.
Using 5 dot/icm genes (icmD, icmQ, icmV, icmW, and dotD) and
several confirmed Coxiella secretion substrates (including
Cbu1751, AnkB, AnkJ, and AnkM), we identified a consensus se-
quence (TTAATATTTTCTTAAGGTTTXTGXGXTAXAAT) (see
Table S3 in the supplementalmaterial) distinct from that reported
by Zusman et al. (22). A genome-wide search with this element
allowed us to obtain 126 candidates, 35 of which have been previ-
ously tested (18); the remaining 83 (see Table S3) were tested in
the current study.
In the second method, we used the E-block feature found in a
large number of Dot/Icm substrates of L. pneumophila (23). One
of the three consensus sequences (EExxE, ExE, or EEx) was found
in 49 Dot/Icm substrates of Coxiella, indicating the usefulness of
thismotif as a reliable predictor of substrate candidates. Using this
feature, we identified 328 ORFs that possess similar motifs. Of
these, 122 ORFs encode hypothetical proteins that were retained
in the candidate pool (see Table S4 in the supplemental material).
Lastly, we scanned the C. burnetii genome for homologs of the
recently identified L. pneumophila Dot/Icm substrates (25), lead-
ing to the identification of 42 candidates, 29 (see Table S5 in the
supplemental material) of which were tested in the current study.
T4SS-dependent translocation of candidate substrates. To
determine Dot/Icm-dependent translocation of these candidates,
each of the 234 genes was fused to the C-terminal end of -lacta-
mase on pCBTEM (18). Plasmids that direct the expression of the
-lactamase fusion proteins were transformed into Lp02 (14), a L.
pneumophila strain with a functional Dot/Icm apparatus. The re-
sulting transformants were used to infect U937 cells at an MOI of
30, and protein translocation was determined by -lactamase-
mediated cleavage of the fluorescence dye CCF4-AM. Fifty-three
proteins were found to cause more than 1% of the U937 cells to
display blue fluorescence. While the majority of these secretion
substrates exhibited a low translocation rate of 10%, four sub-
strates (Cbu0425, Cbu2007, Cbu1620, and CbuA0015) exhibited
a high translocation rate of 90%. When expressed in the dotA
mutant of L. pneumophila, none of these proteins was able to
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promote the delivery of the-lactamase into host cytosol (Table 1
and Fig. 1). Collectively, these results support the designation of
these 53 proteins as substrates of the Dot/Icm T4SS substrates.
To determine whether the protein substrates identified with
the L. pneumophila surrogate host can also be recognized by
the Dot/Icm transporter of C. burnetii, C. burnetii RSA439 or
icmX::Tn was transformed with -lactamase TEM1 fusions listed
in Table S2 in the supplemental material and the resulting trans-
formants were used to infect THP-1 cells. At 48 h postinfection,
cells were loaded with CCF4-AM and incubated for an additional
4 h prior to imaging. RSA439 expressing -lactamase TEM-1 for
each of the substrate fusions was positive for translocation as evi-
dent by the presence of at least 1% blue cells (see Fig. S1A in the
supplemental material) for each tested substrate. Using the con-
stitutive pCC108 and the inducible vector pCBTEM, we were able
to demonstrate translocation of 11 substrates by C. burnetii; how-
ever, we did observe lower expression (data not shown) and lower
translocation using the constitutive pCC108 vector, suggesting
that this may be due to the presence of a promoter weaker than
those in the comparativeC. burnetiiTEMvectors (8, 20). Notably,
Cbu0069, Cbu0113, and Cbu0885 exhibited higher translocation
when expressed in the natural C. burnetii host. No -lactamase
translocation was observed in host cells infected with the RSA439
icmX::Tn strain (see Fig. S1B), indicating that translocation of
these C. burnetii T4SS substrates is dependent on a functional
secretion system and suggesting that they are bona fideC. burnetii
T4SS substrates.
Newly identified C. burnetii Dot/Icm substrates exhibit sig-
nificant plasticity among bacterial isolates. Different isolates of
C. burnetii are associated with unique disease states characterized
by distinct pathological features. For instance, the Dugway (D)
rodent isolate is avirulent compared to NMI (32), whereas the
Graves (G) and Kearns (K) isolates establish an infection charac-
terized by less inflammation and dissemination (33). Comparison
of these different isolates revealed that many effector proteins are
intact in specific group isolates but disrupted in other isolates,
suggesting that different effector proteins may be responsible for
different host cell responses and consequently for distinct disease
states (12, 21, 34).
To compare the heterogeneity characteristics of the newly de-
scribed effectors, details of the genome information for NM,D, K,
and G isolates were compared using PATRIC (35). Among the
proteins identified in this study, only 12 (Cbu0270, Cbu0469,
Cbu0637, Cbu0773, Cbu1079, Cbu1434, Cbu1566, Cbu1754,
Cbu1789, Cbu2007, Cbu2016, and Cbu2076) are fully conserved
among all isolates (see Table S6 in the supplemental material).
Further comparison between the isolates showed that the highest
conservation exists between NMI and Dugway isolates, with an
additional 11 substrates fully conserved.
It is well established that the T4SS translocation signal resides
in the last 100 residues of the C terminus of secretion substrates.
Genome comparison of these isolates revealed that many of these
substrates have C-terminal truncations, suggesting that these sub-
strates may not be translocated by specific isolates and further
supporting the idea of different effector pools for specific C. bur-
netii pathotypes. Many of the substrates have undergone frame-
shifts, resulting in the creation of several pseudogenes. For exam-
ple, Cbu0388 has undergone several frameshifts, leading to the
generation of three separate pseudogenes in K isolates and two
pseudogenes in D isolates. Similarly, Cbu0375 and Cbu0376 have
undergone several mutations resulting in two separate genes in
NMI but in one gene in each of the other three isolates. Such
variationsmay correlate with the requirement of different effector
pools in different disease states during infection.
C. burnetii T4SS substrates target distinct subcellular com-
partments in mammalian cells. Following translocation into a
host cell, many effector proteins target specific subcellular com-
partments or decorate the CCV membrane where they interact
with host proteins (8, 18, 20, 21, 36). To determine host subcellu-
lar compartments targeted by theC. burnetiiT4SS substrates iden-
tified here,C. burnetii-infected or uninfectedHeLa cells were tran-
siently transfected with each substrate expressed as a fusion of
EGFP. Imaging of 52 ectopically expressed substrates identified 17
substrates that displayed a pattern distinct from that seen with
EGFP. Most of these EGFP fusions were diffusely localized
throughout the cytosol andwere excluded from the nuclei (Fig. 2A
and Table 1). All of the tested substrates displayed similar local-
izations in infected and uninfected cells, and no protein was colo-
calized with the Coxiella-containing vacuole (data not shown).
Interestingly, we identified two substrates, Cbu0393 and
Cbu0388, that traffic to the nucleus, indicated by colocalization
with the Hoechst marker (Fig. 2A). Bioinformatics analysis of
these nuclear substrates identified a potential nuclear localization
signal, PPTKRPRGL, in its N-terminal region beginning at resi-
due 11 for Cbu0393 (37) and KKPSKKVKIKKSKPKKKK begin-
ning at residue 922 for Cbu0388.
To better identify the subcellular organelles targeted by these
EGFP-patterned substrate fusions, we conducted colocalization
analysis with markers of relevant organelles. Two substrates,
Cbu0372 and Cbu1576, localized to the endoplasmic reticulum
(ER) as evident by colocalization with the ER marker calnexin
(Fig. 2B). EGFP-CbuA0020 targeted the mitochondria as evident
by colocalization with themitochondrial marker CoxIV (Fig. 2B).
Overexpression of several substrates interferes with yeast
growth. Due to its genetic tractability and the high-level conser-
vation of many cellular processes with mammalian cells, Saccha-
romyces cerevisiae has evolved as a useful model for studying bac-
terial effector proteins (38). A large number of bacterial effectors
have been identified based on their ability to interfere with yeast
growth (12, 27, 39) or by their ability to alter vesicle trafficking
(27, 40). To determine whether any of the C. burnetii T4SS sub-
strates are toxic to yeast, we inserted each of these genes, as well as
previously reported substrates (18), into galactose-inducible vec-
tor pYesNTA2. S. cerevisiaeW303, carrying C. burnetii substrates,
was grown in uracil dropout media, serially diluted, and spotted
onto appropriate dropout agar. Using this approach, we identified
six substrates that severely impaired growth (Fig. 3).
Overexpression ofC. burnetii secretion substrates interferes
with the host secretory pathway. One C. burnetii T4SS effector
has been shown to interfere with vesicle trafficking by disrupting
membrane trafficking using the secreted embryonic alkaline
phosphatase (SEAP) assay (12). To determine whether otherCox-
iella Dot/Icm substrates interfere with the secretory pathway of
eukaryotic cells, Hek293T cells were transiently transfected to
express both the SEAP protein and EGFP substrate fusions. The
ratio of extracellular to intracellular SEAP activity was calculated
(Table 1 and Fig. 4). Three substrates, Cbu1556, Cbu1825, and
CbuA0019, exhibited extracellular/intracellular ratios of 0.23 
0.01 (P 0.0001), 1.70 0.01 (P 0.0004), and 1.36 0.04 (P
0.0002), respectively, which were significantly reduced compared
T4SS Effectors Required for C. burnetii Replication
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TABLE 1 Phenotypes associated with C. burnetii T4SS substrates
Cbu no.
Screen and/or
reference no.a
LP TEM
(%)b Ectopic localizationc Yeast toxicityd SEAPe
Transposon mutant/replication
defectf
Cbu0012g E-block 1 No pattern No phenotype No phenotype Yes/slight defecth
Cbu0041 (cirA) 18 70 Punctate Toxic No phenotype Yes/no intracellular replication
Cbu0069 PmrA 1 No pattern No phenotype No phenotype
Cbu0080 E-block; 12 70 No pattern No phenotype No phenotype
Cbu0113 E-block 7 No pattern No phenotype No phenotype
Cbu0129 18 70 Nucleic No phenotype No phenotype
Cbu0175 18 20 No pattern No phenotype No phenotype
Cbu0183 PmrA 20 No pattern No phenotype No phenotype
Cbu0201g PmrA 1 No pattern No phenotype No phenotype Yes/no defect
Cbu0212 E-block 10 No pattern No phenotype No phenotype
Cbu0270g E-block 1 No pattern No phenotype No phenotype
Cbu0295g E-block; 12 2 No pattern No phenotype No phenotype
Cbu0344 E-block 5 No pattern No phenotype No phenotype Yes/no defect
Cbu0372 E-block 20 Endoplasmic reticulum No phenotype No phenotype Yes/no defect
Cbu0375 E-block 35 No pattern No phenotype No phenotype
Cbu0376 E-block 7 No pattern No phenotype No phenotype
Cbu0388 PmrA 40 Nucleic No phenotype No phenotype Yes/no intracellular replicationh
Cbu0393g PmrA 1 Nucleic No phenotype No phenotype
Cbu0410 18 45 ND No phenotype No phenotype
Cbu0414 18 45 No pattern No phenotype No phenotype
Cbu0425 (cirB) E-block; 12 90 Cytoplasmic No phenotype No phenotype Yes/no intracellular replication
Cbu0469g E-block 1 No pattern No phenotype No phenotype
Cbu0513 E-block 20 Cytoplasmic No phenotype No phenotype
Cbu0590 E-block 70 No pattern No phenotype No phenotype
Cbu0606 E-block 2 Cytoplasmic Toxic No phenotype
Cbu0637g PmrA 1 No pattern No phenotype No phenotype
Cbu0665 PmrA 3 Cytoplasmic No phenotype No phenotype
Cbu0773 E-block 5 No pattern No phenotype No phenotype
Cbu0794 18 80 Nucleic No phenotype No phenotype
Cbu0801 18 10 No pattern No phenotype No phenotype
Cbu0814 18 10 No pattern No phenotype No phenotype
Cbu0881 18 80 ND No phenotype No phenotype
Cbu0885 E-block 1 Cytoplasmic Toxic No phenotype
Cbu0937 (cirC) 18 2 Cytoplasmic No phenotype No phenotype Yes/no intracellular replication
Cbu1045 18 40 No pattern No phenotype No phenotype
Cbu1079 E-block 5 No pattern No phenotype No phenotype
Cbu1102 E-block 70 No pattern No phenotype No phenotype
Cbu1110 PmrA 40 No pattern No phenotype No phenotype
Cbu1150g E-block 1 No pattern No phenotype No phenotype
Cbu1198 PmrA 75 No pattern No phenotype No phenotype Yes/slight defecth
Cbu1217 18 10 No pattern No phenotype No phenotype
Cbu1314 18 2 Nucleic No phenotype No phenotype
Cbu1379g 18 1 No pattern No phenotype No phenotype
Cbu1406 18 40 Cytoplasmic No phenotype No phenotype
Cbu1425g 18 1 Mitochondrial No phenotype No phenotype
Cbu1434g E-block 1 Cytoplasmic No phenotype No phenotype
Cbu1457 18 2 ND No phenotype No phenotype Yes/slight defecth
Cbu1460 18 40 ND No phenotype No phenotype
Cbu1461 18 2 Cytoplasmic No phenotype No phenotype
Cbu1524 12, 18 10 Nucleic Toxic No phenotype
Cbu1525 E-block; 12 Cytoplasmic No phenotype No phenotype
Cbu1543 18 25 Punctate No phenotype No phenotype
Cbu1556 18 50 Cytoplasmic No phenotype 0.23 0.01 Yes/no defect
Cbu1566 E-block 5 No pattern No phenotype No phenotype
Cbu1569 18 90 No pattern No phenotype No phenotype Yes/no defect
Cbu1576 PmrA 2 Endoplasmic reticulum No phenotype No phenotype
Cbu1594 Homolog 5 No pattern No phenotype No phenotype
Cbu1599 18 10 ND No phenotype No phenotype
Cbu1607 E-block 5 No pattern No phenotype No phenotype
Cbu1620 E-block 90 No pattern No phenotype No phenotype
(Continued on following page)
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to the vector-alone ratio of 4.32  0.16, indicating that these C.
burnetii effectors interfere with the host secretory pathway.
C. burnetii T4SS substrates are essential for intracellular
replication and CCV formation. The Legionella pneumophila
Dot/Icm system is estimated to deliver over 250 proteins into the
host cell cytosol. In the L. pneumophila model, loss of a single
effector generally does not diminish bacterial intracellular repli-
cation, suggesting a degree of functional redundancy (41). To
determine whether individualC. burnetii T4SS substrates are nec-
essary for intracellular replication and CCV maturation, we gen-
erated a pool of mutants using the mariner-based Himar1 trans-
poson for random mutagenesis. Rescue cloning and sequencing
analysis led to the isolation of 20 unique T4SS substrate mutants
(Table 1; see also Fig. S2 in the supplemental material).
To determine the effects of each of thesemutations on bacterial
intracellular replication or CCV formation, we infected J774A.1
and HeLa cells with these mutants and monitored bacterial
growth. Whereas several of the substrates were dispensable for
intracellular replication, six substrate mutants (Cbu0041,
Cbu0388, Cbu0425, Cbu0937, Cbu2052, and Cbu2059) were un-
able to replicate in J774A.1 cells (Fig. 5A) or HeLa cells (data not
shown). These mutants displayed a growth phenotype similar to
that of the RSA439 icmX::Tn strain. An additional four substrate
mutants (Cbu0012, Cbu1198, Cbu1457, and Cbu2013) were ca-
pable of replication in J774A.1; however, the bacterial yield was
significantly reduced compared to that of the parental RSA439
(Fig. 5B). None of these mutants were capable of forming the
characteristic large CCV and instead resided in a tight-fitting vac-
uole that did not expand even at late time points following infec-
tion (Fig. 5C). None of these mutants displayed a growth defect
when cultured axenically in ACCM-2 (see Fig. S3A in the supple-
mental material), indicating that the growth defect is not caused
by impairment in general bacterial physiology but likely by the
inability of the mutants to properly interact with host cellular
processes necessary for the establishment of the replicative niche.
Ten substrate mutants exhibited an inability to productively
infect host cells. It was recently demonstrated that coinfection of
an icmD::Tn strain with the isogenic NMII strain rescues this
growth defect by supplying the T4SS functions in trans (13). If the
inability of these effectormutants to replicate intracellularly is due
to the loss of an individual effector function, supplying the effector
function in trans should similarly rescue their growth defect. Con-
focal images of cells infected with individual substrate mutants
resulted in the formation of tight-fitting vacuoles that do not un-
dergo expansion at late time points of infection (Fig. 5C). How-
ever, coinfection of Cbu0041, Cbu0388, Cbu0937, Cbu2052,
Cbu2059, Cbu0425, and Cbu1457 effector mutants with the iso-
genic NMII strain resulted in the formation of CCVs that con-
sisted of roughly equivalent numbers of substrate mutant (red)
and NMII (blue) cells (Fig. 5C), indicating that these transposon
TABLE 1 (Continued)
Cbu no.
Screen and/or
reference no.a
LP TEM
(%)b Ectopic localizationc Yeast toxicityd SEAPe
Transposon mutant/replication
defectf
Cbu1636 18 1 Punctate No phenotype No phenotype Yes/no defect
Cbu1639 PmrA 4 No pattern No phenotype No phenotype Yes/no defect
Cbu1665g E-block 1 No pattern No phenotype No phenotype Yes/no defect
Cbu1677 E-block 5 No pattern No phenotype No phenotype
Cbu1685 PmrA 1 No pattern No phenotype No phenotype
Cbu1751 18 50 No pattern No phenotype No phenotype
Cbu1754 E-block 2 No pattern No phenotype No phenotype
Cbu1769 18 1 No pattern No phenotype No phenotype
Cbu1789g E-block 1 No pattern No phenotype No phenotype
Cbu1790g E-block 1 Cytoplasmic No phenotype No phenotype
Cbu1823 12, 18 50 No pattern No phenotype No phenotype
Cbu1825 12, 18 40 Mitochondrial No phenotype 1.70 0.01
Cbu2007 E-block 90 Cytoplasmic No phenotype No phenotype Yes/no defect
Cbu2013 PmrA 50 Cytoplasmic No phenotype No phenotype Yes/slight defecth
Cbu2016g E-block 1 No pattern Toxic No phenotype Yes/no defect
Cbu2028g E-block 1 No pattern No phenotype No phenotype
Cbu2052 (cirD) 12, 18 90 Cytoplasmic Toxic No phenotype Yes/no intracellular replication
Cbu2059 (cirE) E-block; 12 40 Cytoplasmic No phenotype No phenotype Yes/no intracellular replication
Cbu2064g E-block; 12 1 No pattern No phenotype No phenotype
Cbu2076g E-block 1 No pattern No phenotype No phenotype
Cbu2078 12 10 ND No phenotype No phenotype
CbuA0014 12, 20 10 No pattern No phenotype No phenotype
CbuA0015 E-block, 20 90 No pattern No phenotype No phenotype
CbuA0019g E-block 1 Cytoplasmic No phenotype 1.36 0.04
CbuA0020g E-block 1 Mitochondrial No phenotype No phenotype
a Bioinformatic screen or reference used in identification of T4SS substrates.
b Translocation efficiency of C. burnetii T4SS substrates by L. pneumophilia.
c Subcellular localization of GFP-tagged substrates ectopically expressed in HeLa cells (Fig. 2). ND, not determined.
d Heterologous expression in yeast diminishes replication (Fig. 3).
e External/internal SEAP ratio (Fig. 4). Numbers in bold represent values representing significantly (P 0.01) diminished growth compared to vector and wild-type results.
f Transposon mutants were isolated using rescue cloning, and growth was monitored in J774 and HeLa cells (Fig. 5).
g Putative T4SS substrate with low translocation in Legionella; translocation not confirmed in the natural C. burnetii host.
h Growth defect in single mutant.
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(Tn) effector mutants are capable of replicating in a vacuole coin-
habited by the parental strain. No coinfected cells were observed
for Cbu0012, Cbu1198, and Cbu2013. Therefore, at this time, we
are unable to confirm that these individual substrates are neces-
sary for intracellular replication and CCV formation.
To further verify that the affected substrate genes in these mu-
tants are responsible for the observed phenotypes, we tested three
additional Himar1 insertions each for Cbu0041, Cbu0425,
Cbu0937, Cbu2052, and Cbu2059 that were inserted in the same
positions (see Fig. S2B in the supplemental material) but were
obtained from separate individual transformations. Growth curve
analysis of each mutant in J774A.1 resulted in no intracellular
replication (see Fig. S3), suggesting that the observed growth de-
fect was due to the loss of that individual effector protein and was
unlikely to have been the result of a random point mutation at a
secondary site or due to polar effects. Given their crucial role in
intracellular replication and CCV formation, we renamed
Cbu0041, Cbu0425, Cbu0937, Cbu2052, and Cbu2059 cirA, cirB,
cirC, cirD, and cirE (Coxiella effector for intracellular replication),
respectively. Overall, these results indicate that the growth defect
observed for cirA to -E is due to the loss of an individual effector
protein and thus results in the inability of the mutant bacteria to
form the proper CCV.
DISCUSSION
Using multiple bioinformatics predictions and analyses, we ob-
tained 234 candidates for substrates of theCoxiellaDot/IcmT4SS.
Translocation assays with L. pneumophila as the surrogate host
resulted in the identification of 53 substrates that were secreted in
a Dot/Icm-dependent manner, representing a 22.6% success rate
for substrate identification. Seven substrates identified using
this screen (Cbu0080, Cbu0295, Cbu0425, Cbu1525, Cbu2059,
Cbu2064, and CbuA0015) were previously identified as Dot/Icm
secretion substrates in two independent studies based on genomic
(12) and plasmid QpH1 (20) screens. The identification of 46
novel substrates highlights the effectiveness of using computa-
tional approaches. However, the use of a PmrA consensus se-
quence and E-block motifs did not rediscover many of the previ-
ously reported substrates (12, 18–21). This suggests that the
features governing the recognition of substrate secretion by the
FIG 1 Dot/Icm-dependent translocation of C. burnetii T4SS substrates by L. pneumophila. L. pneumophilawild-type (WT) strain Lp02 or adotA Lp03mutant
expressing -lactamase-fused T4SS substrates was used to infect U937 cells at an MOI of 30. Infected cells were loaded with CCF4/AM, and substrate translo-
cation was determined by counting the number of blue cells. For substrates exhibiting translocation rates above 10%, approximately 1,000 cells were counted;
however, for substrates exhibiting low (less than 10%) translocation rates, approximately 5,000 cells were counted. Results are presented as mean values
determined from triplicate wells from at least two independent experiments.
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Dot/Icm complex are highly diverse and that their expression reg-
ulation characteristics differ significantly.
Cbu0201 (ankC) was previously reported as negative for secre-
tion (19, 21); however, we observed a 1% translocation rate for
this substrate using L. pneumophila as a surrogate host. The dis-
crepancies between these studies canmost likely be attributed to a
difference in the secretion assays used. Here we used the -lacta-
mase TEM-1 assay and observed a 1% translocation rate, whereas
the previous studies used a CyaA assay (19, 21). The differences
between these studies in the results obtained highlight the impor-
tance of using multiple translocation approaches to more com-
prehensively define protein substrates of the Dot/Icm system. Al-
though our results suggest that ankC is a T4SS substrate of
Coxiella, further verification using independent secretion assays in
C. burnetii is needed.
Following translocation into the host cell,many proteins traffic
to specific subcellular compartments where they modulate the
activity of specific host proteins. Subcellular localization has been
used in numerous studies as an important starting point for elu-
cidating effector function (12, 20, 39, 40). We transiently trans-
FIG 2 C. burnetii secretion substrates target distinct subcellular compartments when ectopically expressed in HeLa cells. Each T4SS substrate was expressed as
a C-terminal fusion to EGFP and used for transfection of HeLa cells. (A) A diffuse cytoplasmic signal that excluded the nuclei (Cbu2059) or colocalization with
the nucleus (Cbu0393 and Cbu0388) could be demonstrated. (B) Colocalization analysis identified two substrates (Cbu0372 and Cbu1576) that colocalize with
the endoplasmic reticulummarker calnexin and one substrate (CbuA0020) that colocalizes with the mitochondrial marker CoxIV. Scale bars in merged images
represent 10 m. Arrows denote locations chosen for insets.
FIG 3 C. burnetii T4SS substrates interfere with yeast growth. S. cerevisiae
W303 expressing C. burnetii T4SS substrates was serially diluted to an optical
density at 600 nm (OD600) of 0.2 and spotted onto dropout media containing
2%glucose or 2%galactose. All strains exhibited similar growth characteristics
under noninducing conditions, in the presence of glucose, but exhibited sig-
nificantly diminished growth on galactose-containing media.
FIG 4 C. burnetii-secreted effectors interfere with host protein secretion.
Hek293T cells were cotransfected with pSEAP and GFP-tagged T4SS sub-
strates or a vector control. At 24 h posttransfection, external and internal SEAP
levels were calculated. A significant decrease in SEAP activity was noted for
Cbu1556 (P 0.0001), CbuA0019 (P 0.0002), and Cbu1825 (P 0.0004)
compared to the vector control results.
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fected infected and uninfected HeLa cells with EGFP-tagged T4SS
substrates. Of the 52 substrates examined, 16 fusions displayed a
pattern distinct from the EGFP pattern.Whereas the vastmajority
of these patterns were evenly distributed throughout the cytosol,
distinct localizations of several substrates were observed.
The long-standing coexistence between bacterial pathogens
and eukaryotic hosts has facilitated the evolution of novel meth-
ods for subverting the host innate immune response (42). In the
past decade, several bacterial effectors have been identified that
traffic to the nucleus, where they provoke histone modifications
and facilitate chromatin remodeling (43–46), suggesting that tar-
geting host gene expression is a conserved mechanism used by
intracellular pathogens to combat the host defense. Given that
many intracellular pathogens secrete nuclear effector proteins, we
assessed colocalization of our T4SS substrates with the Hoechst
nuclear marker. We identified two substrates, Cbu0393 and
Cbu0388, which trafficked to the nucleus and encoded a predicted
nuclear localization signal. Interestingly, several additional studies
recently identified three other C. burnetii nuclear substrates,
Cbu1524 (caeA), Cbu1314, and CbuK1976, suggesting that C.
burnetii genes encode a large repertoire of nuclear effectors (12,
18, 47).
C. burnetii has been shown to overcome host defense and to
inhibit host cell death by actively promoting host cell viability by
inducing prosurvival pathways. Modulation of the interplay be-
tween Beclin 1 and Bcl-2 (48) and sustained activation of Akt and
Erk1/2 (9) have been proposed to be mediated by T4SS effectors.
This hypothesis is supported by the characterization of AnkG, aC.
burnetiiT4SS effector that was found to inhibit apoptosis bymod-
ulating p32 (8). An additional 2 effector proteins encoded by nu-
cleus-localized caeA (Cbu1524) and mitochondrion-localized
caeB (Cbu1532) were similarly found to prevent host cell apopto-
sis (47). In the current study, we identified another substrate,
CbuA0020, that colocalized with the CoxIV mitochondrial
marker. It will be interesting to determinewhether thismitochon-
drion-localized protein is similarly capable of inhibiting host cell
apoptosis.
Ectopic expression in yeast has been routinely used to study
bacterial effector proteins. For example, 79 Legionella effectors are
able to significantly impair yeast growth (49), a phenotype that has
been exploited to analyze their biochemical function (50–52). The
identification of Coxiella T4SS substrates capable of inhibiting
yeast growth will provide additional tools in determining their
role in infection. Similarly, specific targeting of these proteins to
distinct host organelles will facilitate future functional analysis.
Recent advances in the field, including the ability to culture the
bacteria axenically in ACCM-2 (24) and to genetically manipulate
the pathogen using a Himar1 transposon (53) and, recently, the
adaptation of a loop-in-loop-out-mediated site-directed mu-
tagenesis method (54), have significantly advanced our under-
standing ofC. burnetiipathogenesis. By applying these tools to our
study, we were able to successfully generate and isolate a pool of
transposon mutants which included 20 T4SS substrate mutants.
Growth curve analysis of each mutant revealed that 10 of these
substrate mutants were unable to replicate intracellularly or form
a characteristic CCV. This intriguing finding suggests less func-
tional redundancy than has been observed for the comparable L.
pneumophilamodel in which only a few effectors, including SdhA
FIG 5 Individual C. burnetii effector proteins are essential for intracellular replication and CCV formation. NMII C. burnetii was transformed with theHimar1
transposon, and the resulting clonal substrate mutants were used to infect J774A.1 cells. (A) Tn insertion into Cbu0041 (cirA), Cbu0388, Cbu0425 (cirB),
Cbu0937 (cirC), Cbu2052 (cirD), and Cbu2059 (cirE) resulted in an inability to replicate intracellularly, however. (B) Tn insertion into Cbu0012, Cbu1198,
Cbu1457, andCbu2013 resulted in reduced intracellular replication compared toRSA439 levels. (C) Todetermine if coinfectionwith parentalNMII strainwould
rescue the growth defect of the Tn mutants, HeLa cells were infected with an MOI of 100 of each strain and incubated for 7 days. Images were captured using a
Nikon A1 confocal microscope, and at least 100 infected cells were imaged per experiment. Coinfection with the wild type resulted in significant replication for
both the wild-type and Tn substrate mutant strains, whereas cells infected only with the substrate mutant did not exhibit significant replication. Scale bars
represent 6 M.
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(55) and AnkB (56), have been shown to be essential for intracel-
lular replication in mammalian cells. Furthermore, a recent study
by O’Connor et al. (41) demonstrated that deletions of large seg-
ments of the L. pneumophila genome result in no impairment in
mammalian intracellular replication; however, these mutants
were significantly impaired in replication in 3 amoeba species. The
differences between these two related bacterial species in effector
redundancy can mostly be attributed to the fact that L. pneumo-
phila is an accidental human pathogen that has developed a large
effector repertoire for growth in a diverse array of protozoa spe-
cies, whereasC. burnetii is a highly adaptedmammalian pathogen
that is capable of replicating in numerous vertebrate species (41).
Each of the cirA-cirE::Tnmutants was observed to be incapable
of efficient intracellular replication, except in cells coinfected with
the isogenic NMII strain. Recent studies have shown that coinfec-
tion of the L. pneumophila ankB mutant with wild-type L. pneu-
mophila was able to rescue the growth defect associated with this
mutant by supplying the effector in trans, highlighting the impor-
tance of individual effector proteins in generating the appropriate
intracellular niche. Similarly, it was demonstrated that the growth
defect associated with aC. burnetii icmD::Tnmutant could also be
rescued by coinfection with the wild type (13). The ability of the
NMII strain to rescue the specific Tn mutants supports the hy-
pothesis that the growth defect observed is the result of the inabil-
ity of the mutants to form the appropriate CCV that results from
the loss of an individual effector protein. This is an intriguing
finding and highlights the importance of individual effector pro-
teins in modulating interactions with the host to facilitate the
appropriate intracellular niche.
Genome comparisons for cirA to -E revealed that only four
substrates (cirA, cirB, cirC, and cirD) are fully conserved among
the different C. burneti pathotypes (18), whereas significant het-
erogeneity exists for cirE. However, cirE has undergone several
frameshifts, raising the issue of whether this substrate is secreted
by other C. burnetii pathotypes. It will be interesting to determine
if each of these substrates is translocated by each of the pathotypes
and if the RSA439 mutants can be complemented by the corre-
sponding K, G, or D DNA.
In conclusion, we have shown that C. burnetii genes encode a
large, unique repertoire of T4SS substrates that traffic to distinct
subcellular compartments and potentially interfere with crucial
host cell processes. Through the use of a Himar1 transposon, we
isolated 20 individual T4SS substrate mutants, 10 of which were
found to be essential for efficient intracellular replication and
CCV formation, indicating a lack of functional effector redun-
dancy. Further study of these effectors, includingmutant comple-
mentation, generation of site-directedmutants, and identification
of host binding partners, is underway to better address the issue of
how each effector facilitates bacterial pathogenesis.
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